Home › NDC Lookup › Ingredients › Salicylic Acid › 10742-1010-02
Oxy 3-IN-1 Acne Cleansing Pads salicylic acid 20 mg For Solution, 115-count — NDC 10742-1010-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Oxy 3-IN-1 Acne Cleansing Pads salicylic acid 20 mg For Solution, 115-count — NDC 10742-1010-2 (Billing 10742-1010-02)

by The Mentholatum Company · 115 FOR SOLUTION in 1 JAR

This is a package of 115 fors of Oxy 3-IN-1 Acne Cleansing Pads salicylic acid 20 mg For Solution from The Mentholatum Company, marketed since Mar 2025 and currently FDA-listed.

NDC 10742-1010-02
🏷️ FDA NDC (as labeled) 10742-1010-2 billing pads the package segment with a zero
This package
Contains115-count Pack sizes2 compare ↓
Product page 10742-1010-01 Also comes in: 90 fors 10742-1010-1
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 10742-1010-2 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
10742 labeler · 1010 product · 2 package
Package marketed since
Mar 3, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC)
0310742023220
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 10742-1010-2
Product NDC 10742-1010
11-digit billing NDC 10742101002
RxCUI 797892
UNII O414PZ4LPZ
UPC 0310742023220
Application # M006
SPL Set ID 4dcc9f0a-24d0-d62e-e063-6394a90aafe2
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-03-03
Route TOPICAL
Dosage form FOR SOLUTION
Substance SALICYLIC ACID
Quick answers
  • RxCUI (RxNorm): 797892
Why two NDCs? The FDA registers this code as 10742-1010-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 10742-1010-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Salicylic acid and derivatives class.

Drug family (ATC) Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It is used in a facial routine for acne-prone and oil-prone skin. The routine includes a cleanser, serum, toner and emulsion. Salicylic acid helps loosen and shed dead skin cells.
  • Use the cleanser morning and evening, and the serum in the morning after cleansing. Use the toner in the evening on dry skin, and the emulsion at night after cleansing. Avoid your...
  • Mild stinging, burning, itching, dryness and extra peeling can happen. If dryness or peeling bothers you, try using the serum or toner every other day. If it gets excessive, stop a...
  • It is best not to. Using another topical acne medication at the same time makes irritation and dryness more likely. If you get irritated, use only one at a time.
📖 Read our full Salicylic Acid Topical guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 90 fors
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
10742-1010-01 10742-1010-1 Main listing 90 FOR SOLUTION in 1 JAR 2025-03-03 — Active
10742-1010-02 You're viewing this 115 FOR SOLUTION in 1 JAR 2025-03-03 — Active

You're viewing the largest of 2 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 115-count package — 115 for solution in 1 jar.
How does this package differ from NDC 10742-1010-01?
Both are Oxy 3-IN-1 Acne Cleansing Pads salicylic acid 20 mg For Solution — the drug itself is identical. This page's package is the 115-count one, while NDC 10742-1010-01 is the 90 fors package.
What NDC number is used to bill for this package of Oxy 3-IN-1 Acne Cleansing Pads salicylic acid 20 mg For Solution?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Stridex Maximum 2 g/100mL 10157-1006-01 Blistex 1 jar — — FDA listed —
Stridex XL Face and Body Pads 2 g/100mL 10157-2114-01 Blistex 1 jar — — FDA listed —
OXY ADVANCED CARE 3 in 1 RETEXTURIZING CLEANSING PADS 20 mg 10742-1000-01 The 90 swabs — — FDA listed —
Oxy Deep Pore Acne Cleansing Pads 20 mg 10742-1006-01 The 90 cloths — — FDA listed —
Oxy 3-IN-1 Acne Cleansing Pads 20 mg 10742-1008-01 The 90 cloths — — FDA listed —
Oxy 3-IN-1 Acne Cleansing Pads 20 mgthis 10742-1010-02 The 115 fors — — FDA listed —
Oxy Deep Pore Acne Cleansing Pads 20 mg 10742-1011-01 The 90 fors — — FDA listed —
OXY ADVANCED CARE MAXIMUM STRENGTH 3-in-1 ACNE PADS 20 mg 10742-1200-01 The 90 swabs — — FDA listed —
OXY Deep Pore Cleansing Pads 20 mg 10742-4204-01 The 90 swabs — — FDA listed —
OXY 3 in 1 Acne Pads 20 mg 10742-4359-01 The 90 swabs — — FDA listed —
Proactiv CLEAR ZONE BODY PADS 2 g/100mL 11410-0056-00 Alchemee, 75 applicators — — FDA listed —
ZO Skin Health Oil Control Pads Acne Treatment 20 mg/mL 42851-0085-30 ZO 30 patches — — FDA listed —
Thayers Since 1847 Natural Remedies Blemish Clearing Witch Hazel Aloe Vera Formula Pads 20 mg/mL 49967-0705-01 L'Oreal 60 applicators — — FDA listed —
Gly-Sal 5-2 Pads .02 g 51326-0038-60 Topiderm, 60 cloths — — FDA listed —
Gly-Sal 10-2 Pads .02 g 51326-0039-60 Topiderm, 60 cloths — — FDA listed —
Gly-Sal 10-2 20 mg 51326-0712-60 Topiderm, 60 cloths — — FDA listed —
Gly-Sal 2-2 Pads 20 mg 51326-0923-01 Topiderm, 60 cloths — — FDA listed —
Max Complexion Correction Pads 2 g/100mL 54031-0501-22 PETER 60 patches — — FDA listed —
Equate Beauty Quick Action Pads Salicylic Acid Acne Treatment 20 mg/mL 61805-0117-01 Bath 90 patches — — FDA listed —
DermaClear Pads 20 mg/g 62742-4076-02 Allure 1 jar — — FDA listed —
Universal Clarifying Pad 20 mg/g 62742-4276-02 Allure 1 jar — — FDA listed —
Clearasil Rapid Rescue Deep Treatment Pads .02 g 63824-0431-90 Reckitt 90 cloths — — FDA listed —
Noxzema ANTIBLEMISH .02 g/g 64942-1259-01 Conopco 0284 g — — FDA listed —
Rush Salicylc Acid Complexion Pads 2 g/100g 65113-1201-01 G.S. 1 jar — — FDA listed —
Anti-Aging Blemish Control Peel Pads 2.366 g/118.29g 65278-0318-01 June 118.29 g — — FDA listed —
Neutrogena Rapid Clear Treatment Pads 20 mg 69968-0719-06 Kenvue 60 cloths — — FDA listed —
Retexturizing Body Pads 2 g/100mm 70381-0126-02 Murad, 1 jar — — FDA listed —
Cleansing Wipes 2 g/100mL 71613-0001-01 Nextcell 25 applicators — — FDA listed —
FHF Change Peel Pads 2 g/100g 72788-0183-02 Summer 1 bottle — — FDA listed —
Acne Correction Pads 2 g/100mL 72957-0012-01 Private 1 jar — — FDA listed —
AHA/BHA Swipes 2 g/100mL 73318-7004-06 SKIN 1 jar — — FDA listed —
ESSENCE BY CATHERINE HINDS PURIFYING PADS with 2% Salicylic Acid 2 g/100mL 76446-0022-50 Anna 1 jar — — FDA listed —
anna lotan PURIFYING PADS with 2% Salicylic Acid 2 g/100mL 76446-0039-50 Anna 1 jar — — Discontinued —
Equate 2% Salicylic acid Acne treatment pad 2 g/100g 79903-0062-01 Walmart, 165 g — — FDA listed —
Maximum Sterngth Cleansing Pads Equate 2 g 79903-0207-01 Walmart 1 jar — — FDA listed —
Tingl Exfoliating Pads 2 g/100g 83286-0011-01 Drmtlgy, 60 patches — — FDA listed —
Crystal Clear Acne Treatment Pads 2 g/100mL 83316-0001-01 Skin 60 patches — — Discontinued —
First Aid Beauty Acne Clearing Pads 2 g/100mL 84126-0119-60 The 60 patches — — FDA listed —
Tula Skincare Breakout Breakthrough Acne Toner Pads 2 g/1001 84126-0152-30 The 1 jar — — FDA listed —
Acne Treatment Cotton Pads 2 g/100g 84356-0003-01 Guangzhou 100 g — — FDA listed —
Societe Clear Skin Pads 2 g/100g 87700-0147-02 Societe 1 jar — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Mar 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII 344S277G0Z
    Allantoin is a naturally derived compound that helps soften and soothe skin. In medicines, it works as a skin-conditioning agent and may help support wound healing and reduce irritation in topical formulations.
  • UNII 8TY5YO42NJ
    Capryloyl glycine is a mild, skin-conditioning ingredient made from a natural fatty acid and the amino acid glycine. In medicines, it acts as a surfactant and preservative booster, helping the product spread evenly and resist contamination.
  • UNII 5EM498GW35
    A mixture of aromatic compounds used to add pleasant smell to the medicine. Fragrance helps mask unpleasant tastes or odors, making the medication easier to take.
  • UNII 96YYQ5TK1K
    A waxy oil derived from jojoba seeds that has been chemically stabilized through hydrogenation. It serves as an emollient and thickener in topical and oral formulations, helping to soften skin contact and improve texture and consistency.
  • UNII O020065R7Z
    A synthetic emulsifier derived from isocetyl alcohol and ethylene oxide. It helps mix oil and water-based ingredients together and improves the texture and stability of creams, lotions, and ointments.
  • UNII CCX72L6NY6
    A synthetic plastic polymer made from polyethylene glycol and a cross-linking agent. It acts as a film-former and binder in medications, helping create smooth coatings on tablets or holding ingredients together in solid dosage forms.
  • UNII 7IGF0S7R8I
    Phytic acid is a naturally occurring compound found in plants that acts as a chelating agent and preservative in medicines. It helps stabilize formulations and prevent oxidation of active ingredients.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 420IP921MB
    A chelating agent derived from edetic acid that binds to metals in the formulation. It helps stabilize the medicine by preventing metal ions from causing breakdown or discoloration.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

11 inactive ingredients listed in the exact product block matched to this NDC.

The official label also stateswater, alcohol, PEG-8/SMDI copolymer, isoceteth-20, allantoin, capryloyl glycine, fragrance, jojoba wax PEG-120 esters, phytic acid, sodium hydroxide, trisodium EDTA

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerThe Mentholatum Company
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code10742
First marketedMar 2025
Product typeHuman Otc Drug
Portfolio108 products on file

More NDCs from The Mentholatum Company labeler code 10742

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 28 words ▾

Uses for the treatment of acne clears acne pimples and allows skin to heal penetrates pores to control blackheads & whiteheads helps prevent new acne pimples from forming

⏱️ Dosage and Administration 67 words ▾

Directions use wipe to clean skin thoroughly cover the entire affected area with a thin layer one to three times daily because excessive drying of the skin may occur, start with one application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day

⚠️ Warnings 91 words ▾

Warnings For external use only When using this product keep away from eyes, lips and mouth. If contact occurs, flush thoroughly with water. skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. do not leave pad on skin If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 5 words ▾

Active ingredient Salicylic acid 2%

🧪 Inactive Ingredients 21 words ▾

Inactive ingredients water, alcohol, PEG-8/SMDI copolymer, isoceteth-20, allantoin, capryloyl glycine, fragrance, jojoba wax PEG-120 esters, phytic acid, sodium hydroxide, trisodium EDTA

🎯 Purpose 3 words ▾

Purpose Acne treatment

📄 When Using This Product 56 words ▾

When using this product keep away from eyes, lips and mouth. If contact occurs, flush thoroughly with water. skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. do not leave pad on skin

🤰 If Pregnant or Breast-Feeding 11 words ▾

If pregnant or breast feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 27 words ▾

Other Information KEEP TIGHTLY CLOSED protect from freezing do not flush keep away from flame, fire and heat avoid storing at temperatures above 100 OF (38 OC)

📄 Questions or Comments 5 words ▾

Questions? 1-877-636-2677 MON-FRI 9AM-5PM (EST)

📄 Package Label / Principal Display Panel 13 words ▾

Principal Display Panel Image 1

Package Label / Principal Display Panel Image 2

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.2K
Claims incl. refills
43
Beneficiaries
35
Spend / beneficiary
$319.01
Spend / claim
$259.66
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by The Mentholatum Company. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 90 fors (10742-1010-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
The Mentholatum Company is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 10742-1009-01 · The 10742-1011-01 · The →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.